Evoke Pharma stock surges over 100%—here’s why

Evoke Pharma Inc (NASDAQ: EVOK) opened well over 100% up on Monday after reporting positive results for a study on its metoclopramide nasal spray. &#1...

What Future Challenges Does Beam Therapeutics Face?

Highlights,Beam Therapeutics Inc. demonstrates a price-to-sales ratio that stands out within the healthcare sector.,Recent revenue growth has been str...

How Is Eli Lilly Expanding Mounjaro's Market Presence?

Highlights,Eli Lilly,(NYSE:LLY),prepares to launch Mounjaro in Hong Kong by the end of the year.,Mounjaro is positioned to be the first drug of its ki...

How Is ImmunoPrecise Antibodies Advancing Research on Aging?

Highlights,ImmunoPrecise Antibodies,(NASDAQ:IPA),contributes to a significant study on mitochondrial dysfunction.,The research aims to enhance underst...

Evoke Pharma Gains Momentum with GIMOTI Study Success

Highlights,Evoke Pharma,(NASDAQ:EVOK),reports positive patient outcomes with GIMOTI nasal spray for diabetic gastroparesis.,A real-world study shows s...

How Will FDA Approval Boost Iterum Therapeutics Stock?

Highlights,Iterum Therapeutics announces a conference call to discuss FDA approval of ORLYNVAH.,The treatment marks a significant milestone as the fir...

Signaturefd LLC Associated with Growth in Exelixis, Inc. Stake

Highlights,Signaturefd LLC increased its holdings in Exelixis, Inc. by 12.2% in the third quarter, reflecting growing confidence in the biotechnology...

Pfizer Management's Turnaround Strategy Being Enhanced Amid Starboar...

Highlights,Pfizer's upcoming quarterly financial report is under scrutiny as activist hedge fund Starboard Value intensifies calls for accountability...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) Announces Encouraging D...

Highlights:,VOQUEZNA® shows rapid relief for heartburn in Non-Erosive GERD.,ACG Outstanding Research Award recognizes significant findings from the PH...

IDEAYA Biosciences, Inc. (Nasdaq:IDYA) Advances with IND Clearance f...

Highlights:,IDEAYA's IDE275 could become a first-in-class treatment for tumors with microsatellite instability.,The Phase 1 trial aims to target a sig...

Olympus CEO steps down amid illegal drug purchase allegations; endos...

Olympus Corp shares fell over 7% on Monday, marking the steepest intraday decline in nearly three months, following the announcement that CEO Stefan K...

How Did Dexcom Beat Expectations Despite Revenue Challenges?

Highlights,Dexcom reports a decline in U.S. revenue despite strong third-quarter results.,The healthcare sector company maintains its full-year revenu...

What Is Iterum Therapeutics' Latest FDA Approval About?

Highlights,Iterum Therapeutics receives FDA approval for its new drug, ORLYNVAH.,ORLYNVAH targets uncomplicated urinary tract infections in adult wome...

Tectonic Advisors LLC Secures 9,958 Shares in Gilead Sciences, Inc....

Highlights,Tectonic Advisors LLC increased its position in Gilead Sciences, Inc. by 15.1% during the third quarter.,Institutional ownership of Gilead...

Shareholders in Bio-Rad Laboratories (NYSE:BIO) Experience 58% Decli...

Highlights,Bio-Rad Laboratories, Inc. has experienced a significant decline in share price, dropping 58% over the past three years.,Recent financial p...

Position in Natera, Inc. (NASDAQ:NTRA) Strengthened by Zweig DiMenna...

Highlights,Zweig DiMenna Associates LLC significantly increased its stake in Natera, Inc. by 213% during the third quarter.,Natera's recent earnings r...

Boston Scientific's Strong Performance: A Positive Outlook Ahead

Headlines,Boston Scientific delivers impressive quarterly earnings, surpassing expectations.,Analysts provide optimistic outlooks, adjusting price tar...

Why Did Zynex Receive FDA Clearance for Its New Device?

Highlights,Zynex Inc. reports an increase in orders for its pain management devices.,The company secures FDA clearance for its new TensWave device.,Zy...

Why Did Merck’s KEYTRUDA Secure Two New EU Approvals?

Highlights,Merck gains two new EU approvals for KEYTRUDA in gynecologic cancers.,Approvals cover treatments for advanced endometrial and cervical canc...

Strong Earnings Propel Laboratory Co. of America Stock Higher

Headlines,Laboratory Co. of America experiences significant stock increase,Strong earnings exceed expectations, boosting market confidence,Upcoming di...